Literature DB >> 25367873

Early-onset Crohn's disease and autoimmunity associated with a variant in CTLA-4.

Sebastian Zeissig1, Britt-Sabina Petersen2, Michal Tomczak3, Espen Melum4, Emilie Huc-Claustre5, Stephanie K Dougan3, Jon K Laerdahl6, Björn Stade2, Michael Forster2, Stefan Schreiber7, Dascha Weir8, Alan M Leichtner8, Andre Franke2, Richard S Blumberg3.   

Abstract

OBJECTIVE: IBD is a group of complex, systemic disorders associated with intestinal inflammation and extraintestinal manifestations. Recent studies revealed Mendelian forms of IBD, which contributed significantly to our understanding of disease pathogenesis and the heritability of IBD.
DESIGN: We performed exome sequencing in a family with Crohn's disease (CD) and severe autoimmunity, analysed immune cell phenotype and function in affected and non-affected individuals, and performed in silico and in vitro analyses of cytotoxic T lymphocyte-associated protein 4 (CTLA-4) structure and function.
RESULTS: A novel missense variant was identified in CTLA4 encoding CTLA-4, a coinhibitory protein expressed by T cells and required for regulation of T cell activation. The residue affected by the mutation, CTLA-4 Tyr60, is evolutionarily highly conserved, and the identified Y60C variant is predicted to affect protein folding and structural stability and demonstrated to cause impaired CTLA-4 dimerisation and CD80 binding. Intestinal inflammation and autoimmunity in carriers of CTLA-4 Y60C exhibit incomplete penetrance with a spectrum of clinical presentations ranging from asymptomatic carrier status to fatal autoimmunity and intestinal inflammation. In a clinically affected CTLA-4 Y60C carrier, T cell proliferation was increased in vitro and associated with an increased ratio of memory to naive T cells in vivo, consistent with impaired regulation of T cell activation.
CONCLUSIONS: Our results support the concept that variants in CTLA4 provide the basis for a novel Mendelian form of early-onset CD associated with systemic autoimmunity. Incomplete penetrance of autoimmunity further indicates the presence of other genetic and/or environmental modifiers. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/

Entities:  

Keywords:  CROHN'S DISEASE; GENE MUTATION; IMMUNOLOGY; IMMUNOREGULATION

Mesh:

Substances:

Year:  2014        PMID: 25367873      PMCID: PMC4512923          DOI: 10.1136/gutjnl-2014-308541

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  55 in total

1.  Primary deficiency of microsomal triglyceride transfer protein in human abetalipoproteinemia is associated with loss of CD1 function.

Authors:  Sebastian Zeissig; Stephanie K Dougan; Duarte C Barral; Yvonne Junker; Zhangguo Chen; Arthur Kaser; Madelyn Ho; Hannah Mandel; Adam McIntyre; Susan M Kennedy; Gavin F Painter; Natacha Veerapen; Gurdyal S Besra; Vincenzo Cerundolo; Simon Yue; Sarah Beladi; Samuel M Behar; Xiuxu Chen; Jenny E Gumperz; Karine Breckpot; Anna Raper; Amanda Baer; Mark A Exley; Robert A Hegele; Marina Cuchel; Daniel J Rader; Nicholas O Davidson; Richard S Blumberg
Journal:  J Clin Invest       Date:  2010-07-01       Impact factor: 14.808

2.  Abatacept for Crohn's disease and ulcerative colitis.

Authors:  William J Sandborn; Jean-Frederic Colombel; Bruce E Sands; Paul Rutgeerts; Stephan R Targan; Remo Panaccione; Brian Bressler; Karl Geboes; Stefan Schreiber; Richard Aranda; Sheila Gujrathi; Allison Luo; Yun Peng; Luisa Salter-Cid; Stephen B Hanauer
Journal:  Gastroenterology       Date:  2012-04-12       Impact factor: 22.682

3.  Enterocolitis in patients with cancer after antibody blockade of cytotoxic T-lymphocyte-associated antigen 4.

Authors:  Kimberly E Beck; Joseph A Blansfield; Khoi Q Tran; Andrew L Feldman; Marybeth S Hughes; Richard E Royal; Udai S Kammula; Suzanne L Topalian; Richard M Sherry; David Kleiner; Martha Quezado; Israel Lowy; Michael Yellin; Steven A Rosenberg; James C Yang
Journal:  J Clin Oncol       Date:  2006-05-20       Impact factor: 44.544

4.  Induction of FoxP3 and acquisition of T regulatory activity by stimulated human CD4+CD25- T cells.

Authors:  Mindi R Walker; Deborah J Kasprowicz; Vivian H Gersuk; Angele Benard; Megan Van Landeghen; Jane H Buckner; Steven F Ziegler
Journal:  J Clin Invest       Date:  2003-11       Impact factor: 14.808

5.  Interleukin-10-deficient mice develop chronic enterocolitis.

Authors:  R Kühn; J Löhler; D Rennick; K Rajewsky; W Müller
Journal:  Cell       Date:  1993-10-22       Impact factor: 41.582

6.  XIAP variants in male Crohn's disease.

Authors:  Yvonne Zeissig; Britt-Sabina Petersen; Snezana Milutinovic; Esther Bosse; Gabriele Mayr; Kenneth Peuker; Jelka Hartwig; Andreas Keller; Martina Kohl; Martin W Laass; Susanne Billmann-Born; Heide Brandau; Alfred C Feller; Christoph Röcken; Martin Schrappe; Philip Rosenstiel; John C Reed; Stefan Schreiber; Andre Franke; Sebastian Zeissig
Journal:  Gut       Date:  2014-02-26       Impact factor: 23.059

7.  Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4.

Authors:  P Waterhouse; J M Penninger; E Timms; A Wakeham; A Shahinian; K P Lee; C B Thompson; H Griesser; T W Mak
Journal:  Science       Date:  1995-11-10       Impact factor: 47.728

8.  X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy.

Authors:  R S Wildin; F Ramsdell; J Peake; F Faravelli; J L Casanova; N Buist; E Levy-Lahad; M Mazzella; O Goulet; L Perroni; F D Bricarelli; G Byrne; M McEuen; S Proll; M Appleby; M E Brunkow
Journal:  Nat Genet       Date:  2001-01       Impact factor: 38.330

9.  The orphan receptor CRF2-4 is an essential subunit of the interleukin 10 receptor.

Authors:  S D Spencer; F Di Marco; J Hooley; S Pitts-Meek; M Bauer; A M Ryan; B Sordat; V C Gibbs; M Aguet
Journal:  J Exp Med       Date:  1998-02-16       Impact factor: 14.307

10.  From next-generation sequencing alignments to accurate comparison and validation of single-nucleotide variants: the pibase software.

Authors:  Michael Forster; Peter Forster; Abdou Elsharawy; Georg Hemmrich; Benjamin Kreck; Michael Wittig; Ingo Thomsen; Björn Stade; Matthias Barann; David Ellinghaus; Britt-Sabina Petersen; Sandra May; Espen Melum; Markus B Schilhabel; Andreas Keller; Stefan Schreiber; Philip Rosenstiel; Andre Franke
Journal:  Nucleic Acids Res       Date:  2012-09-10       Impact factor: 16.971

View more
  52 in total

Review 1.  The Treatment of Inflammatory Bowel Disease in Patients with Selected Primary Immunodeficiencies.

Authors:  Dror S Shouval; Matthew Kowalik; Scott B Snapper
Journal:  J Clin Immunol       Date:  2018-06-29       Impact factor: 8.317

2.  Molecular Pathways of Colon Inflammation Induced by Cancer Immunotherapy.

Authors:  Adrienne M Luoma; Shengbao Suo; Hannah L Williams; Tatyana Sharova; Keri Sullivan; Michael Manos; Peter Bowling; F Stephen Hodi; Osama Rahma; Ryan J Sullivan; Genevieve M Boland; Jonathan A Nowak; Stephanie K Dougan; Michael Dougan; Guo-Cheng Yuan; Kai W Wucherpfennig
Journal:  Cell       Date:  2020-06-29       Impact factor: 41.582

Review 3.  Genetic basis of autoimmunity.

Authors:  Alexander Marson; William J Housley; David A Hafler
Journal:  J Clin Invest       Date:  2015-06-01       Impact factor: 14.808

Review 4.  Environment and Genes: What Is the Interaction?

Authors:  Richard S Blumberg
Journal:  Dig Dis       Date:  2016-03-16       Impact factor: 2.404

Review 5.  Inflammatory bowel disease and cancer response due to anti-CTLA-4: is it in the flora?

Authors:  Franck Carbonnel; Emilie Soularue; Clélia Coutzac; Nathalie Chaput; Christine Mateus; Patricia Lepage; Caroline Robert
Journal:  Semin Immunopathol       Date:  2017-01-16       Impact factor: 9.623

Review 6.  The role of monogenic disease in children with very early onset inflammatory bowel disease.

Authors:  Judith R Kelsen; Robert N Baldassano
Journal:  Curr Opin Pediatr       Date:  2017-10       Impact factor: 2.856

Review 7.  Genomic and Immunologic Drivers of Very Early-Onset Inflammatory Bowel Disease.

Authors:  Maire A Conrad; Judith R Kelsen
Journal:  Pediatr Dev Pathol       Date:  2019-03-06

Review 8.  Immune checkpoint inhibitors: new strategies to checkmate cancer.

Authors:  R A M Wilson; T R J Evans; A R Fraser; R J B Nibbs
Journal:  Clin Exp Immunol       Date:  2017-12-27       Impact factor: 4.330

9.  Phenotype, penetrance, and treatment of 133 cytotoxic T-lymphocyte antigen 4-insufficient subjects.

Authors:  Charlotte Schwab; Annemarie Gabrysch; Peter Olbrich; Virginia Patiño; Klaus Warnatz; Daniel Wolff; Akihiro Hoshino; Masao Kobayashi; Kohsuke Imai; Masatoshi Takagi; Ingunn Dybedal; Jamanda A Haddock; David M Sansom; Jose M Lucena; Maximilian Seidl; Annette Schmitt-Graeff; Veronika Reiser; Florian Emmerich; Natalie Frede; Alla Bulashevska; Ulrich Salzer; Desirée Schubert; Seiichi Hayakawa; Satoshi Okada; Maria Kanariou; Zeynep Yesim Kucuk; Hugo Chapdelaine; Lenka Petruzelkova; Zdenek Sumnik; Anna Sediva; Mary Slatter; Peter D Arkwright; Andrew Cant; Hanns-Martin Lorenz; Thomas Giese; Vassilios Lougaris; Alessandro Plebani; Christina Price; Kathleen E Sullivan; Michel Moutschen; Jiri Litzman; Tomas Freiberger; Frank L van de Veerdonk; Mike Recher; Michael H Albert; Fabian Hauck; Suranjith Seneviratne; Jana Pachlopnik Schmid; Antonios Kolios; Gary Unglik; Christian Klemann; Carsten Speckmann; Stephan Ehl; Alan Leichtner; Richard Blumberg; Andre Franke; Scott Snapper; Sebastian Zeissig; Charlotte Cunningham-Rundles; Lisa Giulino-Roth; Olivier Elemento; Gregor Dückers; Tim Niehues; Eva Fronkova; Veronika Kanderová; Craig D Platt; Janet Chou; Talal A Chatila; Raif Geha; Elizabeth McDermott; Su Bunn; Monika Kurzai; Ansgar Schulz; Laia Alsina; Ferran Casals; Angela Deyà-Martinez; Sophie Hambleton; Hirokazu Kanegane; Kjetil Taskén; Olaf Neth; Bodo Grimbacher
Journal:  J Allergy Clin Immunol       Date:  2018-05-04       Impact factor: 10.793

Review 10.  Rare phenotypes in the understanding of autoimmunity.

Authors:  Yvonne Zeissig; Britt-Sabina Petersen; Andre Franke; Richard S Blumberg; Sebastian Zeissig
Journal:  Immunol Cell Biol       Date:  2016-10-11       Impact factor: 5.126

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.